scholarly journals Dermal adipocytes protect against invasive Staphylococcus aureus skin infection

Science ◽  
2015 ◽  
Vol 347 (6217) ◽  
pp. 67-71 ◽  
Author(s):  
Ling-juan Zhang ◽  
Christian F. Guerrero-Juarez ◽  
Tissa Hata ◽  
Sagar P. Bapat ◽  
Raul Ramos ◽  
...  

Adipocytes have been suggested to be immunologically active, but their role in host defense is unclear. We observed rapid proliferation of preadipocytes and expansion of the dermal fat layer after infection of the skin by Staphylococcus aureus. Impaired adipogenesis resulted in increased infection as seen in Zfp423nur12 mice or in mice given inhibitors of peroxisome proliferator–activated receptor γ. This host defense function was mediated through the production of cathelicidin antimicrobial peptide from adipocytes because cathelicidin expression was decreased by inhibition of adipogenesis, and adipocytes from Camp−/− mice lost the capacity to inhibit bacterial growth. Together, these findings show that the production of an antimicrobial peptide by adipocytes is an important element for protection against S. aureus infection of the skin.

2019 ◽  
Vol 51 (12) ◽  
pp. 1-10 ◽  
Author(s):  
Yi Sak Kim ◽  
Prashanta Silwal ◽  
Soo Yeon Kim ◽  
Tamotsu Yoshimori ◽  
Eun-Kyeong Jo

AbstractMycobacterium tuberculosis (Mtb) is a major causal pathogen of human tuberculosis (TB), which is a serious health burden worldwide. The demand for the development of an innovative therapeutic strategy to treat TB is high due to drug-resistant forms of TB. Autophagy is a cell-autonomous host defense mechanism by which intracytoplasmic cargos can be delivered and then destroyed in lysosomes. Previous studies have reported that autophagy-activating agents and small molecules may be beneficial in restricting intracellular Mtb infection, even with multidrug-resistant Mtb strains. Recent studies have revealed the essential roles of host nuclear receptors (NRs) in the activation of the host defense through antibacterial autophagy against Mtb infection. In particular, we discuss the function of estrogen-related receptor (ERR) α and peroxisome proliferator-activated receptor (PPAR) α in autophagy regulation to improve host defenses against Mtb infection. Despite promising findings relating to the antitubercular effects of various agents, our understanding of the molecular mechanism by which autophagy-activating agents suppress intracellular Mtb in vitro and in vivo is lacking. An improved understanding of the antibacterial autophagic mechanisms in the innate host defense will eventually lead to the development of new therapeutic strategies for human TB.


2006 ◽  
Vol 5 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Neil E. Alexis ◽  
Marianne S. Muhlebach ◽  
David B. Peden ◽  
Terry L. Noah

1987 ◽  
Vol 20 (10) ◽  
pp. 2421-2426
Author(s):  
Takao SAITO ◽  
Kenji ZEZE ◽  
Akihiko KUWAHARA ◽  
Masaki MIYAHARA ◽  
Katsuhiro SHIMODA ◽  
...  

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Ivan Ramirez-Moral ◽  
Bianca Lima Ferreira ◽  
Alex F. de Vos ◽  
Tom van der Poll

AbstractAgonists of peroxisome proliferator-activated receptor (PPAR)-γ have been suggested as potential adjuvant therapy in bacterial pneumonia because of their capacity to inhibit inflammation and enhance bacterial clearance. Previous studies only assessed the effects of pretreatment with these compounds, thereby bearing less relevance for the clinical scenario. Moreover, PPAR-γ agonists have not been studied in pneumonia caused by Klebsiella pneumoniae, a common human respiratory pathogen of which antibiotic treatment is hampered by increasing antimicrobial resistance. Here we show that administration of the PPAR-γ agonist pioglitazone 6 or 8 h after infection of mice with a highly virulent strain of Klebsiella pneumoniae via the airways results in reduced cytokine and myeloperoxidase levels in the lungs at 24 h after infection, as well as reduced bacterial growth in the lungs and decreased dissemination to distant organs at 42 h post-infection. These results suggest that pioglitazone may be an interesting agent in the treatment of Klebsiella pneumonia.


Critical Care ◽  
2013 ◽  
Vol 17 (Suppl 4) ◽  
pp. P111
Author(s):  
Crisitina Nagae ◽  
Cassiano Gonçalves-de-Albuquerque ◽  
Alessandra Ferreira ◽  
Raysa Captivo ◽  
Larissa Camisão ◽  
...  

2008 ◽  
Vol 105 (36) ◽  
pp. 13532-13537 ◽  
Author(s):  
G. Hajishengallis ◽  
M. Wang ◽  
S. Liang ◽  
M. Triantafilou ◽  
K. Triantafilou

Sign in / Sign up

Export Citation Format

Share Document